Number of the records: 1
喹唑啉化合物
- 1.0534384 - ÚOCHB 2021 RIV chi P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
喹唑啉化合物.
[Quinazoline compounds.]
2020. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.07.2020. Patent Number: TWI699355
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=TW&NR=I699355B&KC=B&FT=D&ND=4&date=20200721&DB=&locale=en_EP
本發明所述為化學式 (I) 的化合物及其互變異構物與其藥學鹽、 含有此等化合物的組合物及製劑， 以及使用及製造此等化合物的方法。
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.
Permanent Link: http://hdl.handle.net/11104/0312833
Number of the records: 1